| Tafamidis |
EU/1/11/717/002 |
Vyndaqel, Capsule, soft, 20, mg, Pack: 90 |
Pfizer Limited, Обединено Кралство |
Penn Pharmaceutical Services Limited, Обединено кралство |
61837.22 |
12367.44 |
74204.66 |
4% |
10 |
61847.22 |
12369.44 |
74216.66 |
16% |
25 |
61872.22 |
12374.44 |
74246.66 |
|
НСР-5765/09.03.2015 |
23.03.2015 |
23.03.2015 |
Неактивен |
3641 |
| Tafamidis |
EU/1/11/717/001 |
Vyndaqel, Capsule, soft, 20, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Penn Pharmaceutical Services Ltd. 23-24 Tafarnaubach Estate,Tredegar, Gwent NP2 3AA, Обединено кралство |
21697.27 |
4339.45 |
26036.72 |
4% |
10 |
21707.27 |
4341.45 |
26048.72 |
16% |
25 |
21732.27 |
4346.45 |
26078.72 |
цената е заличена с решение НСР-6186/08.05.2015 ( в сила от 02.06.2015 ) |
НСР-4596/15.09.2014 |
30.09.2014 |
30.09.2014 |
Заличен |
3208 |
| Tafamidis |
EU/1/11/717/001 |
Vyndaqel, Capsule, soft, 20, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Penn Pharmaceutical Services Ltd. 23-24 Tafarnaubach Estate,Tredegar, Gwent NP2 3AA, Обединено кралство |
21709.71 |
4341.94 |
26051.65 |
4% |
10 |
21719.71 |
4343.94 |
26063.65 |
16% |
25 |
21744.71 |
4348.94 |
26093.65 |
|
НСР-2751/17.02.2014 |
06.03.2014 |
06.03.2014 |
Неактивен |
3208 |
| Tafamidis |
EU/1/11/717/001 |
Vyndaqel, Capsule, soft, 20, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Penn Pharmaceutical Services Ltd. 23-24 Tafarnaubach Estate,Tredegar, Gwent NP2 3AA, Обединено кралство |
22571.73 |
4514.35 |
27086.08 |
4% |
10 |
22581.73 |
4516.35 |
27098.08 |
16% |
25 |
22606.73 |
4521.35 |
27128.08 |
|
HCР-20/31.05.2013 |
02.06.2013 |
02.06.2013 |
Неактивен |
3208 |
| Valsartan |
20120307 |
Walzera, Film coated tablet, 160, mg, Pack: 30 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Šlandrova ulica 4, 1231 Ljubljana, Črnuče, Словения |
8.64 |
1.73 |
10.37 |
7% |
0.6 |
9.24 |
1.85 |
11.09 |
20% |
1.73 |
10.97 |
2.19 |
13.16 |
|
НСР-8338/26.02.2016 |
16.03.2016 |
16.03.2016 |
Активен |
1479 |
| Valsartan |
20120306 |
Walzera, Film coated tablet, 80, mg, Pack: 30 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Šlandrova ulica 4, 1231 Ljubljana, Črnuče, Словения |
6.85 |
1.37 |
8.22 |
7% |
0.48 |
7.33 |
1.47 |
8.8 |
20% |
1.37 |
8.7 |
1.74 |
10.44 |
цената се заличава HCР-451/09.07.2013 |
КЦРР-1731/04.12.2012 г |
20.12.2012 |
20.12.2012 |
Заличен |
1478 |
| Valsartan |
20120307 |
Walzera, Film coated tablet, 160, mg, Pack: 30 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Šlandrova ulica 4, 1231 Ljubljana, Črnuče, Словения |
9.78 |
1.96 |
11.74 |
7% |
0.68 |
10.46 |
2.09 |
12.55 |
20% |
1.96 |
12.42 |
2.48 |
14.9 |
|
КЦРР-1731/04.12.2012 г |
20.12.2012 |
20.12.2012 |
Неактивен |
1479 |
| Coagulation factor VIII, Factor von Willebrand |
20110734 |
Wilate 1000, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutika Produktionsges, m.b.H. Oberlaaerstr.235 A-1100 Vienna, Австрия |
772.47 |
154.49 |
926.96 |
4% |
10 |
782.47 |
156.49 |
938.96 |
16% |
25 |
807.47 |
161.49 |
968.96 |
цената е вписана в регистъра на пределените цени НСР-6059/16.04.2015 (в сила от 16.05.2015 ) |
НСР-5155/27.11.2014 |
11.12.2014 |
11.12.2014 |
Заличен |
3419 |
| Coagulation factor VIII, Factor von Willebrand |
20110734 |
Wilate 1000, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutika Produktionsges, m.b.H. Oberlaaerstr.235 A-1100 Vienna, Австрия |
782.33 |
156.47 |
938.8 |
4% |
10 |
792.33 |
158.47 |
950.8 |
16% |
25 |
817.33 |
163.47 |
980.8 |
Оставена без разглеждане жалба на Комисия по прозрачност КП-33/09.04.2014 |
НСР-1794/25.11.2013 |
16.04.2014 |
16.04.2014 |
Неактивен |
3419 |
| Coagulation factor VIII, Factor von Willebrand |
ІІ-12959/05.05.2006 г. |
WILATE 450 powder for solution for injection 450 IU x 1, Powder and solvent for solution for injection, 450, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutica Productionsges GmbH, Austria |
792.11 |
158.42 |
950.53 |
4% |
10 |
802.11 |
160.42 |
962.53 |
16% |
25 |
827.11 |
165.42 |
992.53 |
Цената се заличава с решение НСР-3931/30.06.2014 ( в сила от 02.08.2014) |
КЦ-835/23.04.2009 |
15.05.2009 |
15.05.2009 |
Заличен |
723 |
| Coagulation factor VIII, Factor von Willebrand |
20110733 |
Wilate 500, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutika Produktionsges, m.b.H. Oberlaaerstr.235 A-1100 Vienna, Австрия |
383.81 |
76.76 |
460.57 |
4% |
10 |
393.81 |
78.76 |
472.57 |
16% |
25 |
418.81 |
83.76 |
502.57 |
Отхвърлена като неоснователна жалбата от Комисия по прозрачност с решение КП-394/06.11.2015 |
НСР-7055/03.09.2015 |
02.12.2015 |
02.12.2015 |
Активен |
3418 |
| Coagulation factor VIII, Factor von Willebrand |
20110733 |
Wilate 500, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutika Produktionsges, m.b.H. Oberlaaerstr.235 A-1100 Vienna, Австрия |
386.24 |
77.25 |
463.49 |
4% |
10 |
396.24 |
79.25 |
475.49 |
16% |
25 |
421.24 |
84.25 |
505.49 |
|
НСР-5154/27.11.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3418 |
| Coagulation factor VIII, Factor von Willebrand |
20110733 |
Wilate 500, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutika Produktionsges, m.b.H. Oberlaaerstr.235 A-1100 Vienna, Австрия |
391.17 |
78.23 |
469.4 |
4% |
10 |
401.17 |
80.23 |
481.4 |
16% |
25 |
426.17 |
85.23 |
511.4 |
Оставена без разглеждане жалба на Комисия по прозрачност КП-33/09.04.2014 |
НСР-1794/25.11.2013 |
16.04.2014 |
16.04.2014 |
Неактивен |
3418 |
| Coagulation factor VIII, Factor von Willebrand |
ІІ-12959/05.05.2006 г. |
WILATE 900 powder for solution for injection 900 IU x 1, Powder and solvent for solution for injection, 900, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutica Productionsges GmbH, Austria |
704.1 |
140.82 |
844.92 |
4% |
10 |
714.1 |
142.82 |
856.92 |
16% |
25 |
739.1 |
147.82 |
886.92 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-4/05.02.2014; Цената се заличава с решение НСР-3931/30.06.2014 ( в сила от 02.08.2014) |
КЦРР-2256/11.02.2013 |
02.04.2014 |
02.04.2014 |
Заличен |
2556 |
| Coagulation factor VIII, Factor von Willebrand |
ІІ-12959/05.05.2006 г. |
WILATE 900 powder for solution for injection 900 IU x 1, Powder and solvent for solution for injection, 900, IU, Pack: 1 |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutica Productionsges GmbH, Austria |
1584.22 |
316.84 |
1901.06 |
4% |
10 |
1594.22 |
318.84 |
1913.06 |
16% |
25 |
1619.22 |
323.84 |
1943.06 |
|
КЦ-835/23.04.2009 |
15.05.2009 |
15.05.2009 |
Неактивен |
2556 |
| Latanoprost, Timolol |
20060549 |
XALACOM, Eye drops, solution, 0,125 mg/12,5mg - 2,5 ml, mg, Pack: 1 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
11.13 |
2.23 |
13.36 |
6% |
0.67 |
11.8 |
2.36 |
14.16 |
18% |
2 |
13.8 |
2.76 |
16.56 |
промяна на обстоятелства НСР-9753/14.07.2016 |
НСР-2752/17.02.2014; НСР-9366/19.05.2016 |
02.07.2016 |
02.08.2016 |
Активен |
2538 |
| Latanoprost, Timolol |
20060549 |
XALACOM, Eye drops, solution, 0,125 mg/12,5mg - 2,5 ml, mg, Pack: 1 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
11.13 |
2.23 |
13.36 |
6% |
0.67 |
11.8 |
2.36 |
14.16 |
18% |
2 |
13.8 |
2.76 |
16.56 |
|
НСР-2752/17.02.2014; НСР-9366/19.05.2016 |
02.07.2016 |
02.07.2016 |
Неактивен |
2538 |
| Latanoprost, Timolol |
II-14440/ 13.10.2006 |
XALACOM, Eye drops, solution, 0,125 mg/12,5mg - 2,5 ml, mg, Pack: 1 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
12.81 |
2.56 |
15.37 |
6% |
0.77 |
13.58 |
2.72 |
16.3 |
18% |
2.31 |
15.89 |
3.18 |
19.07 |
|
НСР-2752/17.02.2014 |
06.03.2014 |
06.03.2014 |
Неактивен |
2538 |
| Latanoprost, Timolol |
II-14440/ 13.10.2006 |
XALACOM, Eye drops, solution, 0,125 mg/12,5mg - 2,5 ml, mg, Pack: 1 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
17.95 |
3.59 |
21.54 |
6% |
1.08 |
19.03 |
3.81 |
22.84 |
18% |
3.23 |
22.26 |
4.45 |
26.71 |
|
КЦРР-709/05.06.2012 |
21.06.2012 |
21.06.2012 |
Неактивен |
2538 |
| Latanoprost, Timolol |
II-14440/13.10.2006 |
XALACOM, Eye drops, solution, 0,125 mg/12,5mg - 2,5 ml, mg, Pack: 1 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
29.44 |
5.89 |
35.33 |
8% |
2.36 |
31.8 |
6.36 |
38.16 |
20% |
5.89 |
37.69 |
7.54 |
45.23 |
|
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
2538 |
| Latanoprost |
9900241 |
Xalatan, Eye drops, solution, 50 mcg/ml - 2,5 ml, mcg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
8.92 |
1.78 |
10.7 |
7% |
0.62 |
9.54 |
1.91 |
11.45 |
20% |
1.78 |
11.32 |
2.26 |
13.58 |
промяна обстоятелства НСР-9856/21.07.2016 |
НСР-8977/14.04.2016. |
30.04.2016 |
02.09.2016 |
Активен |
2423 |
| Latanoprost |
II-10816/12.05.2005 |
Xalatan, Eye drops, solution, 50 mcg/ml - 2,5 ml, mcg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
8.92 |
1.78 |
10.7 |
7% |
0.62 |
9.54 |
1.91 |
11.45 |
20% |
1.78 |
11.32 |
2.26 |
13.58 |
|
НСР-8977/14.04.2016. |
30.04.2016 |
30.04.2016 |
Неактивен |
2423 |
| Latanoprost |
II-10816/12.05.2005 |
Xalatan, Eye drops, solution, 50 mcg/ml - 2,5 ml, mcg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
11.11 |
2.22 |
13.33 |
6% |
0.67 |
11.78 |
2.36 |
14.14 |
18% |
2 |
13.78 |
2.76 |
16.54 |
|
НСР-2331/13.01.2014 |
05.02.2014 |
05.02.2014 |
Неактивен |
2423 |
| Latanoprost |
II-10816/12.05.2005 |
Xalatan, Eye drops, solution, 50 mcg/ml - 2,5 ml, mcg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
17.6 |
3.52 |
21.12 |
6% |
1.06 |
18.66 |
3.73 |
22.39 |
18% |
3.17 |
21.83 |
4.37 |
26.2 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2423 |
| Latanoprost |
II-10816/12.05.2005 |
Xalatan, Eye drops, solution, 50 mcg/ml - 2,5 ml, mcg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
26.29 |
5.26 |
31.55 |
6% |
1.58 |
27.87 |
5.57 |
33.44 |
18% |
4.73 |
32.6 |
6.52 |
39.12 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2423 |